Sign Up to like & get
recommendations!
0
Published in 2024 at "Molecular Oncology"
DOI: 10.1002/1878-0261.13746
Abstract: Cancers can develop resistance to treatment with ALK tyrosine kinase inhibitors (ALK‐TKIs) via emergence of a subpopulation of drug‐tolerant persister (DTP) cells that can survive initial drug treatment long enough to acquire genetic aberrations. DTP…
read more here.
Keywords:
cell;
inhibitor;
gpx4;
bypass ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-425
Abstract: Introduction: Targeted therapies provide clinical benefits in patients harboring oncogene-driven cancers, but relapses invariably occur. Studies on resistance mechanisms are essential to guide the development of next-generation inhibitors. An increasing number of studies focus on…
read more here.
Keywords:
cell;
tolerant;
dtp cells;
drug ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2025.1586552
Abstract: Acute myeloid leukemia (AML) exhibits a pronounced ability to develop drug resistance and undergo disease relapse. Recent research has noticed that resistance to treatments could substantially be attributed to drug-tolerant persister (DTP) cells, which are…
read more here.
Keywords:
persister;
acute myeloid;
drug;
myeloid leukemia ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14102562
Abstract: Simple Summary Drug tolerant persister (DTP) cells are a unique, small sub-population of cancer cells that maintain viability under anti-cancer cytotoxic treatments. These cells enter into a reversible drug-tolerant state, which is believed to be…
read more here.
Keywords:
breast cancer;
dtp cells;
gdf15;
biomarker ... See more keywords